GB1360759A - 3-oxy-iminomethyl cephalosporin compounds - Google Patents

3-oxy-iminomethyl cephalosporin compounds

Info

Publication number
GB1360759A
GB1360759A GB5593872A GB5593872A GB1360759A GB 1360759 A GB1360759 A GB 1360759A GB 5593872 A GB5593872 A GB 5593872A GB 5593872 A GB5593872 A GB 5593872A GB 1360759 A GB1360759 A GB 1360759A
Authority
GB
United Kingdom
Prior art keywords
alkyl
group
protected
alkanoyl
tert
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5593872A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of GB1360759A publication Critical patent/GB1360759A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3

Abstract

1360759 3-Oxyiminomethyl cephalosporins ELI LILLY & CO 4 Dec 1972 [23 Dec 1971] 55938/72 Heading C2A New 3-oxyiminomethyl cephalosporins of the formula wherein n is 0 or 1; R is H, C 1-8 alkanoyl, C 2-8 - chloro- or bromo-alkanoyl, azidoacetyl, cyanoacetyl, wherein each Q is H or Me and Ar denotes 2- or 3-thienyl, 2- or 3-furyl, 2- or 3- pyrrolyl, phenyl or phenyl substituted with Cl, Br, I, F, CF 3 , OH, C 1-3 alkyl, C 1-3 alkoxy, CN, or NO 2 (at least one substituent being in the m- or pposition in the ring), G-X-CH 2 -C(O)- where X is O or S and G is as Ar above or may be 4-pyridyl when X is S, Ar-CHB-C(O)- where Ar is as defined above and B denotes -NH 2 , -NH 3 <SP>+</SP>, an amino group protected with a benzyloxycarbonyl, a C 1-4 alkoxycarbonyl, cyclopentyloxycarbonyl, cyclohexyl oxycarbonyl, benzhydryloxycarbonyl, triphenylmethyl, 2,2,2-trichloroethoxy carbonyl, -SO 3 H, phthalimido, the enamine from methyl acetoacetate or acetyl acetone, or B is -OH or -OH protected by esterification with a C 1-6 alkanoic acid, -COOH or a -COOH group protected by esterification with a C 1-6 alkanol, or B is -N 3 , -CN, or -C(O)NH 2 , or R is 2- sydnone-3-C 1-3 alkanoyl or where m is 0, 1 or 2, 5-aminoadipoyl in which the amino group is optionally protected with a C 1-3 alkanoyl or C 1-3 chloroalkanoyl group and those aminoadipoyl groups in which the carboxy groups are protected with benzhydryl, 2,2,2- trichloroethyl, C 4-6 alkyl or nitrobenzyl; R<SP>1</SP> is H or R and R<SP>1</SP> together with the nitrogen atom to which they are attached denote -NH 3 <SP>+</SP>, a salt group with an acid having a pKa of less than 4, or a cyclic imide group from a C 3-12 hydrocarbon dicarboxylic acid; the group in which Z is (-CH 2 -) y when y is 1 or 2 or Z is -O-, or R and R<SP>1</SP> taken together with the nitrogen atom denotes R<SP>2</SP> is C 4-6 tert.-alkyl, C 5-7 tert.-alkenyl, C 5-7 tert.- alkynyl, benzyl, methoxybenzyl, nitrobenzyl, 2,2,2 - trichloroethyl, 3,5 - di - tert. - butyl - 4- hydroxybenzyl, acetoxymethyl, pivaloyloxymethyl, 2-iodoethyl, benzhydryl, phenacyl, trimethylsilyl, succinimidomethyl, phthalimidomethyl or hydrogen, and Y is H, C 1-6 alkyl, C 2-6 haloalkyl (halo = Cl or Br), C 6-12 aromatic hydrocarbon, C 4-7 cycloalkyl, C 1-3 alkylene-XC 1-3 alkyl where X is O or S, -CH 2 COOR<SP>3</SP> where R<SP>3</SP> is H or C 1-6 alkyl, or -CH 2 -CH 2 -N(CH 3 ) 2 are prepared by reacting the corresponding 3- formal cephalosporins of formula wherein R, R<SP>1</SP>, R<SP>2</SP> and n are as defined above, with hydroxylamine, an O-substituted-N-unsubstituted hydroxylamine of formula H 2 N-O-Y (where Y is as defined above) or a salt thereof. Salts with pharmaceutically acceptable anions may be prepared in the usual ways. Pharmaceutical compositions comprising the active compounds of the invention and conventional carriers and excipients may be used as therapeutic antibiotic compositions for oral or parenteral administration.
GB5593872A 1971-12-23 1972-12-04 3-oxy-iminomethyl cephalosporin compounds Expired GB1360759A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21174871A 1971-12-23 1971-12-23

Publications (1)

Publication Number Publication Date
GB1360759A true GB1360759A (en) 1974-07-24

Family

ID=22788205

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5593872A Expired GB1360759A (en) 1971-12-23 1972-12-04 3-oxy-iminomethyl cephalosporin compounds

Country Status (1)

Country Link
GB (1) GB1360759A (en)

Similar Documents

Publication Publication Date Title
GB1526978A (en) 3-thiosubstituted cephalosporin antibiotics
CZ280583B6 (en) Antibacterial preparation
IE41474L (en) Thiomethylergolines
GB1459065A (en) Therapeutic thiophene derivatives
ES423531A1 (en) Alpha-aminoacyl-3-halo-cephalosporins
GB1505885A (en) Substituted cephalosporins
GB1456221A (en) 3-hydroxy cephalosporins their ether derivatives and methods for their preparation
IE43123B1 (en) Tetrazolethiomethyl cephalosporin compounds
GB1360759A (en) 3-oxy-iminomethyl cephalosporin compounds
GB1432714A (en) 7- alpha-halomethyl-arly- acetamide- cephalosporin derivatives
ATE212637T1 (en) ANTIBIOTICALLY EFFECTIVE CEPHALOSPORINS AND METHOD FOR THE PRODUCTION THEREOF
GB1457668A (en) Cephalo
GB1497039A (en) Penicillins and cephalosporins
EP0025271B1 (en) Derivatives of clavulanic acid, their preparation and pharmaceutical compositions containing them
GB1432925A (en) 7-alpha-cyanomethylaryl-acetamide-cephalosporins
IL41020A (en) 3-oximinomethyl cephalosporin derivatives and their preparation
GB1505345A (en) Cephalosporins
GB1466954A (en) 3-oxyiminomethyl or oxyiminoethyl- cephalasporins their preparation and use
GB1360860A (en) Cepham compounds process for their manufacture and compositions containing them
DE3341591C2 (en)
GB1505848A (en) 3,4-dicarboxycephalosporins and derivatives
US4705784A (en) Cephem compounds
WO1998039311A1 (en) Antibacterial heterocyclic amino acid derivatives
GB1526499A (en) Cyclopentanol derivatives
GB1203805A (en) Cephalosporin derivatives and a process for preparing the same

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee